EURODRUG LABORATORIES B V has a total of 14 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2009. It filed its patents most often in Brazil, Philippines and Australia. Its main competitors in its focus markets pharmaceuticals are HANGZHOU HUAHUI MEDICINE TECH CO LTD, LIU GUIYUAN and YU KEAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 3 | |
#2 | Philippines | 2 | |
#3 | Australia | 1 | |
#4 | Chile | 1 | |
#5 | Colombia | 1 | |
#6 | Dominican Republic | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Peru | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Assandri Alessandro | 7 |
#2 | Alessandro Assandri | 3 |
#3 | Van Gulik Frederick | 2 |
#4 | Frederick Van Gulik | 2 |
#5 | Prabha Shankar Bodapunti | 2 |
#6 | Rao Yamsani Madhusudan | 2 |
#7 | Gannu Ramesh | 1 |
#8 | Suresh Bandari | 1 |
#9 | Bandari Suresh | 1 |
#10 | Shankar Bodapunti Prabha | 1 |
Publication | Filing date | Title |
---|---|---|
MX2017013352A | Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions. |